CEO Anders Elias Hanson Vaccex November 2016 – Present (1 year 8 months) | Copenhagen Area, Capital Region, Denmark VacceX has been founded based on proprietary technology licensed from the Technical University of Denmark. VacceX is establishing a pipeline of drugs for immunotherapy treatment in combination with radiotherapy and furthermore aims to establish partnerships with companies in need of a delivery technology for immunotherapeutic drugs.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.